Mask Use Experiences, COVID-19, and Adults with Asthma: A Mixed Methods Approach

Posted: 2021-11-17 20:00:00
Background: While masks are recommended for those with asthma in the era of COVID-19, there is limited research exploring the extent of and problems related to mask use in adults with asthma. Objective: We sought to describe in adults with asthma: 1) the extent masks are worn and attitudes and beliefs about wearing masks; (2) participant characteristics associated with problems experienced while wearing a mask, and (3) participant experiences and recommendations regarding masks. Methods: The Mask Use in Adults with Asthma online survey was conducted with 501 adults with asthma primarily (96.6%) from the United States. A Mask Effects Scale (MES) was compiled from items addressing problems experienced wearing a mask with higher total scores indicating more problems. Open-ended questions explored factors considered when choosing a mask, problems experienced while wearing a mask, and recommendations to others with asthma. Survey data were analyzed descriptively and via multiple regression. Themes were generated from open-ended items. Results: Almost all participants (98.4%) indicated wearing a mask in public and most (67.4%) wore a mask ≤3 hours per day. Poorer asthma control and wearing a mask longer were significantly associated with higher MES scores (P≤.001 & .005, respectively). Participant recommendations included "Just wear it", use a comfortable, well-fitting mask, take mask breaks, and carry your inhaler. Conclusions: Wearing a mask in public was almost uniformly adhered to by participants, despite reporting problematic effects. Implementing recommendations, such as planned mask breaks, can support and enhance the experience of wearing a mask for adults with asthma. Keywords: Asthma; Asthma control; COVID-19; Coronavirus; Face coverings; Masks.

参考サイト PubMed: covid-19


12月 07, 2020 バイオアソシエイツ


2020年11月14日にThe Journal of Extracellular Vesiclesのオンラインで公開されたオープンアクセスの論文で、イェール大学医学部内科リウマチ学および臨床免疫学部門医学病理学教授のPhilip Askenase医学博士(写真)は、重度の COVID-19 患者の場合、間葉系幹細胞(MSC)由来の エキソソーム…

ゲスト 900人 と メンバー 4人 がオンラインです